{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:29:28Z","timestamp":1792225768789,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtct.2024.08.016","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T13:44:08Z","timestamp":1724507048000},"page":"1099.e1-1099.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective Study"],"prefix":"10.1016","volume":"30","author":[{"given":"Xiaowei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunte","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9650-2758","authenticated-orcid":false,"given":"Ruiqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-8440","authenticated-orcid":false,"given":"Liangliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jtct.2024.08.016_bib0001","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2024.08.016_bib0002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2024.08.016_bib0003","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s12185-015-1881-2","article-title":"Impairment of hematopoietic stem cell niches in patients with aplastic anemia","volume":"102","author":"Wu","year":"2015","journal-title":"International Journal of Hematology"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12185-017-2217-1","article-title":"Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia","volume":"106","author":"Wu","year":"2017","journal-title":"International Journal of Hematology"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gendis.2023.03.027","article-title":"Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia","volume":"11","author":"Chen","year":"2024","journal-title":"Genes & Diseases"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41408-024-01021-x","article-title":"Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia","volume":"14","author":"Wu","year":"2024","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-022-01324-1","article-title":"Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2024.08.016_bib0008","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bbmt.2018.07.018","article-title":"Allogeneic hematopoietic stem cell transplantation for the treatment of severe aplastic anemia patients with infection: a single-center retrospective study","volume":"24","author":"Xu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2024.08.016_bib0009","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bbmt.2019.03.020","article-title":"Comparable outcomes of first-line hematopoietic stem cell transplantation from unrelated and matched sibling donors in adult patients with aplastic anemia: a retrospective single-center study","volume":"25","author":"Zhang","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.08.016_bib0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbmt.2016.12.628","article-title":"Alternative donor transplantation with high-dose post-transplantation cyclophosphamide for refractory severe aplastic anemia","volume":"23","author":"DeZern","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2024.08.016_bib0011","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/bmt.2010.213","article-title":"Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia","volume":"46","author":"DeZern","year":"2011","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1016\/j.jtct.2024.08.016_bib0012","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2024.08.016_bib0013","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3026(22)00206-X","article-title":"Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial","volume":"9","author":"DeZern","year":"2022","journal-title":"The Lancet Haematology"},{"issue":"7","key":"10.1016\/j.jtct.2024.08.016_bib0014","doi-asserted-by":"crossref","first-page":"463.e461","DOI":"10.1016\/j.jtct.2023.04.015","article-title":"Prospective study of a modified post-transplantation cyclophosphamide regimen for severe aplastic anemia patients with HLA-haploidentical transplantation","volume":"29","author":"Wu","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.jtct.2024.08.016_bib0015","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1016\/j.bbmt.2020.05.023","article-title":"A case series of post-transplantation cyclophosphamide in unrelated donor hematopoietic cell transplantation for aplastic anemia","volume":"26","author":"Arcuri","year":"2020","journal-title":"Biology of Blood and Marrow Transplantation:Jjournal of the American Society for Blood and Marrow Transplantation"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0016","doi-asserted-by":"crossref","first-page":"48.e41","DOI":"10.1016\/j.jtct.2022.10.006","article-title":"Alternative transplantation with post-transplantation cyclophosphamide in aplastic anemia: a retrospective report from the BMF-WG of Hunan Province, China","volume":"29","author":"Gong","year":"2023","journal-title":"Transplantation and Cellular Therapy"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0017","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40164-021-00215-4","article-title":"Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma","volume":"10","author":"Chen","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2024.08.016_bib0018","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12185-022-03355-3","article-title":"Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine-bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma","volume":"116","author":"Beynarovich","year":"2022","journal-title":"International Journal of Hematology"},{"issue":"9","key":"10.1016\/j.jtct.2024.08.016_bib0019","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41409-022-01725-3","article-title":"Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia","volume":"57","author":"Lazzari","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2024.08.016_bib0020","doi-asserted-by":"crossref","first-page":"396.e391","DOI":"10.1016\/j.jtct.2022.04.021","article-title":"Comparisons of modified post-transplantation cyclophosphamide and granulocyte colony-stimulating factor\/antithymocyte globulin regimens for haploidentical stem cell transplantation in patients with aplastic anemia","volume":"28","author":"Li","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2024.08.016_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101078","article-title":"Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: recent advances and modification","volume":"62","author":"Li","year":"2023","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.jtct.2024.08.016_bib0022","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI124218","article-title":"Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression","volume":"129","author":"Wachsmuth","year":"2019","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jtct.2024.08.016_bib0023","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162180","article-title":"Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide","volume":"8","author":"Sumii","year":"2023","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.jtct.2024.08.016_bib0024","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3026(22)00206-X","article-title":"Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial","volume":"9","author":"DeZern","year":"2022","journal-title":"The Lancet Haematology"},{"issue":"11","key":"10.1016\/j.jtct.2024.08.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356152","article-title":"Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF\/ATG induced GVHD protective activity and improve haploidentical transplant outcomes","volume":"6","author":"Wang","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-019-0781-y","article-title":"Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients","volume":"12","author":"Wang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2024.08.016_bib0027","article-title":"Low-dose post-transplant cyclophosphamide with G-CSF\/ATG based haploidentical protocol provides favorable outcomes for SAA patients","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbmt.2010.06.014","article-title":"The outcome of unrelated hematopoietic stem cell transplants with total body irradiation (800 cGy) and cyclophosphamide (120 mg\/kg) in adult patients with acquired severe aplastic anemia","volume":"17","author":"Lee","year":"2011","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jtct.2024.08.016_bib0029","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbmt.2017.10.034","article-title":"Post-transplant cyclophosphamide as sole graft-versus-host disease prophylaxis is feasible in patients undergoing peripheral blood stem cell transplantation for severe aplastic anemia using matched sibling donors","volume":"24","author":"George","year":"2018","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib32","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1016\/j.clnves.2024.100001","article-title":"Advances in cancer treatment: The role of new technologies and research","volume":"1","author":"Zeng","year":"2025","journal-title":"Cell Investigation"},{"issue":"3","key":"10.1016\/j.jtct.2024.08.016_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cei\/uxac047","article-title":"CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCT","volume":"208","author":"Fan","year":"2022","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1016\/j.jtct.2024.08.016_bib0031","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-022-01287-3","article-title":"Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant","volume":"15","author":"Zhao","year":"2022","journal-title":"Journal of Hematology & Oncology"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T01:53:05Z","timestamp":1762048385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724006092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666636724006092"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.016","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}